To investigate the effects of L-carnitine (LCAR) and N-acetylcysteine (NAC) on carbon tetrachloride (CCl 4 )-induced acute liver damage in rats. Material and methods: Totally, 40 rats in 5 groups were included in the study. The fi rst group was the control group. Group 2 received CCl 4 (2 ml/kg). Group 3 was given CCl 4 + NAC (150 mg/kg). The rats in the Group 4 were administered CCl 4 + LCAR (100 mg/kg), and the rats in the Group 5 were given CCl 4 + NAC + LCAR. Both CCl 4 and the treatment protocols were administered via intraperitoneal route for 10 days. Tissue oxidative stress and antioxidant markers were investigated in liver tissue and serum liver enzymes were measured. Results: The levels of blood liver enzymes (ALT and AST) increased signifi cantly in the Group 2. However, they decreased markedly in all treatment groups. While malondialdehyde and myeloperoxidase levels in the liver tissue samples increased signifi cantly in the 2nd group, those levels were determined to be decreased significantly in all treatment groups. When the liver tissue antioxidant levels were evaluated; reduced glutathione and catalase decreased markedly in the 2nd group, but increased following the administration of NAC and LCAR. The activities of liver tissue superoxide dismutase did not differ signifi cantly among the groups. In the histopathologic evaluation of liver tissues, on the other hand, diffuse hepatosteatosis was observed in all groups except the control group and there was no signifi cant difference among the groups from the point of steatosis. Conclusion: LCAR and NAC were concluded to have benefi cial effects on the acute liver damage induced by CCl 4 administration (Tab. 1, Fig. 5, Ref. 52). Text in PDF www.elis.sk.
The acute effect of carbon tetrachloride (CCl 4 ) causes morphological changes in hepatocyte endoplasmic reticulum (1) . The toxic effect of CCl 4 on the liver is explained by the free radical (CCl 3 ) formed by the biotransformation of the former, resulting in lipid peroxidation (2, 3) . When the free oxygen radicals formed as the result of this toxic effect enter into a reaction with unsaturated acids of the lipids in cell membranes, the membranes are destroyed. Lipid breakdown products formed by lipid peroxidation may eliminate sulfhydryl groups of various enzymes and other proteins. Lipid peroxidation may also lead to the breakdown of lysosomal membrane and thus, destructive enzymes may spill into the cytoplasm. CCl 4 causes hydropic degeneration, steatosis and hepatocellular zone 3 necrosis (4).
L-carnitine (LCAR) is an antioxidant and prevents the accumulation of end products of lipid peroxidation (6) . In order to explain the effects of carnitine, several mechanisms have been proposed. Carnitine (β-hydroxy-N-trimethylaminobutyric acid) plays a major role, as a cofactor, in the transportation of free fatty acids (FFAs) from the cytosol to the mitochondria. FFAs degrade to acyl-CoA by β-oxidation and these substances enter the tricarboxylic acid (TCA) cycle. A large amount of O 2 is consumed in this reaction and ATP is synthesized in the steps of the electron transport chain and oxidative phosphorylation. O 2 is reduced to H 2 O at the end of the TCA cycle and the O 2 concentration decreases. Thus, toxic products such as ROS and products of FFA are cleared from the cell (7) . Administration of LCAR stimulates β-oxidation of fatty acids and reduces the esterifi cation of triglycerides (8) . Bertelli et al found that LCAR was effective by decreasing liver lipid infi ltration and lipid peroxidation in liver damage induced by administration of hyperbaric oxygen and ethanol (9) . N-acetylcysteine (NAC) is the acetylated precursor of both the amino acid L-cysteine and GSH. Historically it has been used as a mucolytic agent in chronic respiratory illnesses as well as an antidote for hepatotoxicity due to acetaminophen overdose (10) . More recently, various experimental studies of NAC have shown it to be a powerful antioxidant and a potential therapeutic agent in the treatment of cancer (11) , heart disease (12), colitis (13) , and pancreatitis (14) , characterized by free-radical oxidant damage. On the other hand, benefi cial effects of NAC have been demonstrated in acute and chronic liver damage (15, 16) .
In view of the above fi ndings, we aimed to demonstrate the possible benefi cial effects of LCAR and NAC on acute liver damage caused by CCl 4.
Animals and methods

Animals and experimental protocol
The structure of this study and animal experimental procedures were approved by the Ethics Committee of Kahramanmaras Sutcu Imam University School of Medicine. Forty Wistar albino rats, weighing 160-180 g, were obtained from the Kahramanmaras Sutcu Imam University School of Medicine Experimental Research Centre (Kahramanmaras, Turkey). They were kept in stainless steel cages in the animal room, which was maintained on a 12-h-light / 12-h-dark cycle at 21-22 °C. The rats were allowed free access to food and water ad libitum.
Wistar rats were divided into fi ve groups (8 rats in each group).
Group I (control): Only 0.2 ml olive oil was given intraperitoneally (IP) to the rats each day throughout ten days.
Group II (CCl 4 Group): 2 ml/kg CCl 4 mixed with olive oil with a rate of 1:1 was given intraperitoneally to the rats for ten days.
Group III (CCl 4 + LCAR Group): 2 ml/kg CCl 4 mixed with olive oil with a rate of 1:1 and 100 mg/kg LCAR were administrated intraperitoneally to the rats for ten days.
Group IV (CCl 4 + NAC Group): 2 ml/kg CCl 4 mixed with olive oil with a rate of 1:1 and 150 mg/kg NAC were given intraperitoneally to the rats for ten days.
Group V (CCl 4 + NAC + LCAR Group): 2 ml/kg CCl 4 mixed with olive oil with a rate of 1:1 and additionally 150 mg/kg NAC and 100 mg/kg LCAR were administered intraperitoneally to the rats for ten days.
At the end of the experiment, 3 rats from the Group II and one rat from the Group IV died. Intracardiac blood was drawn from the remaining rats under general anesthesia for biochemical analysis and then they were sacrifi ed by decapitation. Following sacrifi cation, liver tissues of the rats were obtained for histopathologic examination and tissue biochemistry. The sera of the blood obtained were separated and kept in -80 °C for later analysis. Liver tissues were kept in formaldehyde solution for histopathologic examination, and in -80 °C for biochemical analysis. Liver tissues were homogenized with 10 volumes of ice-cold 0.25 M sucrose, centrifugated at 14,000 rpm to measure the biochemical parameters in resulting supernatant.
Measurement of Liver Enzymes
Intracardiac blood was drawn from the rats under general anesthesia for biochemical analysis at the end of the experiment and then they were sacrifi ed. The sera were separated and alanine transaminase (ALT), aspartate transaminase (AST), alkaline phosphatase (ALP) and gama glutamyl transpeptidase (GGT) levels were analyzed in Immulite 2000 autoanalyzer.
Lipid peroxidation levels
Lipid peroxidation level in the tissue samples was expressed by malondialdehyde (MDA). It was measured according to the procedure of Ohkawa et al (17) . The reaction mixture contained 0.1 ml tissue sample, 0.2 ml of 8.1 % sodium dodecyl sulphate (SDS), 1.5 ml of 20 % acetic acid and 1.5 ml of 0.8 % aqueous solution of thiobarbituric acid. The mixture pH was adjusted to 3.5 and volume was fi nally made up to 4.0 ml with distilled water and 5.0 ml of the mixture of n-butanol and pyridine (15:1,v/v) was added. The mixture was shaken vigorously. After centrifugation at 4000 rpm for 10 min, the absorbance of the organic layer was measured at 532 nm. MDA level was expressed as nmol/mg protein.
Myeloperoxidase activities
Myleoperoxidase (MPO) activity was determined by a modifi cation of the O-dianisidine method (18) . The assay mixture, in a cuvette of 1 cm path length, contained 0.3 ml 0.1 M phosphate buffer (pH 6.0), 0.3 ml 0.01 M H 2 0 2 , 0.5 ml 0.02 M O-dianisidine (freshly prepared) in deionized water and 10 microliter supernatant in a fi nal volume of 3.0 ml. The supernatant was added at last and the change in absorbance at 460 nm was followed for 10 min. All measurements were carried out in duplicate. One unit of MPO was defi ned as that giving an increase in absorbance of 0.001 per min and specifi c activity was given as U/mg protein.
Superoxide dismutase Activity
Superoxide dismutase (SOD) activity was measured according to the method described by Fridovich (19) . This method employs xanthine and xanthine oxidase to generate superoxide radicals, which react with p-iodonitrotetrazolium violet (INT) to form a red formazan dye which was measured at 505 nm. Assay medium consisted 0.01 M phosphate buffer, CAPS (3-cyclohexilamino-1-propanesulfonicacid) buffer solution (50 mM CAPS, 0.94 mM EDTA, satd. NaOH) with pH 10.2, solution of substrate (0.05 Mm xanthine, 0.025 mM INT) and 80 UL xanthine oxidase. SOD activity was expressed as U/mg protein.
Measurement of Glutathione
Reduced glutathione (GSH) level was determined according to method of Beutler (20) . The reaction mixture contained fi ltrate, phosphate buffer and DTNB (5,5'-dithiobis 2-nitrobenzoic acid) in fi nal volume of 10 ml. A blank was also prepared by using precipitating reagent and distilled water instead of fi ltrate. The absorbances were immediately read in a spectrophotometer at 412 nm before and after addition of DTNB. The values were determined from the standard curve. GSH level was expressed as μmol/mg protein.
Catalase activity
Catalase (CAT) activities were determined by measuring the decrease in hydrogen peroxide concentration at 230 nm by the method of Beutler (20) . The assay medium consisted 1 M Tris HCI, 5 mM Na 2 EDTA buffer solution (pH 8.0), 1 M phosphate buffer solution (pH 7.0), and 10 mM H 2 O 2 . CAT activity was expressed as U/mg protein.
Histopathological Evaluation of Liver Samples
Postmortem liver excision was performed at the end of the experiment and sections of liver tissues were obtained with a thick-ness of 0.5 cm. The tissue fi xed in buffered 10 % formaldehyde was embedded in paraffi n blocks. Then 4 μm thick sections were obtained from the blocks and stained with Haematoxylin-Eosin and examined under the light microscope.
Statistical analyses
All data were expressed as the mean ± SD. Groups of data were compared with an analysis of Kruskal-Wallis followed by Mann-Whitney U multiple comparison tests. Values of p<0.05 were regarded as signifi cant.
Results
The levels of ALT and AST were found to be increased signifi cantly in CCl 4 administered group compared to the control and decreased following the addition of either NAC or LCAR. However, the decrease in the levels of ALT and AST was observed to be statistically signifi cant only in LCAR+NAC administered group. On the other hand, the levels of ALP and GGT were found not to differ markedly among the groups (Tab. 1).
When the levels of MDA, determinant of lipid peroxidation, was evaluated, it was found to be increased in CCl 4 group compared to the control and decreased markedly in all treated groups (Group III, IV and V) (Fig. 1) . However, no signifi cant difference was detected among the control and treated groups from the point of MDA levels.
When the levels of MPO were evaluated, MPO was found to be increased signifi cantly in CCl 4 group compared to the control and decreased markedly in III, IV and V groups (Fig. 2) . No signifi cant difference was detected among the control, III, IV and V. groups. The data were given as the mean ± SD. * p<0.05, was found statistically signifi cantly higher than control group. ** p<0.05, was found statistically signifi cantly lower than CCl 4 group. As the markers of antioxidant status, levels of GSH, SOD and CAT were evaluated in the liver tissue. When the levels of GSH in the liver tissue were evaluated, they were found to be decreased signifi cantly in CCl 4 group compared to the control and re-approximated to the levels of control following the treatment with NAC and LCAR (Fig. 3) . Also, no signifi cant difference was detected among the control and NAC, LCAR and NAC+LCAR groups.
Tab
Similar to the changes in GSH levels, the levels of CAT in the liver tissue decreased signifi cantly in CCl 4 group compared to the control and administration of NAC and LCAR increased the levels of CAT signifi cantly compared to the CCl 4 group (Fig. 4) . On the other hand, when the levels of SOD were evaluated, no statistical difference was detected among the groups even though the levels of SOD increased slightly in the CCl 4 and treatment groups compared to the control.
Diffuse steatosis in the liver was observed in histopathologic examination in all groups (Groups II, III, IV and V) but the control. No other pathology was observed except steatosis. There was no signifi cant difference among the groups from the aspect of degree of steatosis (Figs 5A-B) .
Discussion
LCAR stimulates beta-oxidation of fatty acids. In case of LCAR defi ciency, mitochondrial fatty acid oxidation is impaired and fat deposition occurs in the cytoplasm of liver cells. Deposited fat, in turn, impairs the functions of liver (21) . The level of LCAR in the liver tissue was shown to decrease in cases with cirrhosis (22) . LCAR, on the other hand, was shown to have protecting effects against lipid peroxidation, steatosis and necrosis in the liver injury caused by ethanol (23) . Moreover, antioxidant effects of NAC in various cases in which oxidative stress took part in were shown in many experimental studies (11) (12) (13) (14) 24) .
NAC was also shown to have benefi cial effects in acute and chronic liver injuries. Galicia-Moreno M and co-workers demonstrated the benefi cial effects of NAC through oxidative stress and profi brinogenic mechanisms in experimental liver cirrhosis formed by CCl 4 administration (15) . In another study, benefi cial effects of NAC and desferoxamin were demonstrated in experimental acute liver damage formed by CCl 4 (16) . The effects of NAC and LCAR separately in acute liver injury were investigated. However, any study investigating the effects of both antioxidant agents together could not be found in literature. We found in that thesis a study that NAC and LCAR together decreased the oxidative stress markers and levels of liver enzymes in acute liver injury formed by CCl 4 exposure.
One of the most frequently used agents in forming liver injury in experimental studies is CCl 4 and the free oxygen radicals released during its enzymatic metabolism are the basic factor of cellular injury caused by CCl 4 . The cellular injury associated with CCl 4 is caused by either binding of the radicals to the cellular components by covalent bonds or increased lipid peroxidation (25, 26) .
Monooxygenase system of the endoplasmic reticulum has a role in the metabolism of CCl 4 . Unstable trichlormethyl peroxide complex is structured by the cytochrom p-450 isoenzyme and converted into trichlormethyl peroxide by oxygen (27). The early change in CCl 4 hepatotoxicity takes place as lipid deposition in liver and blockage in lipoprotein secretion (28) . Following the damage caused by CCl 4 , lipid peroxidation becomes effective. Radicals of CCl 4 were demonstrated to lead lipid changes in the endoplasmic reticulum. Cytotoxic products originating from microsomal lipids of the liver cause diffuse cellular injury (29) . Free oxygen radicals and lipid peroxidation as well as other factors are thought to be responsible in the pathogenesis of fatty and infi ltrative liver diseases.
LCAR was shown to be deposited in muscle and brain tissue in general in various studies. It is deposited in the liver tissue as well. It was reported that extrarenal excretion of LCAR was increased when LCAR was given intraperitoneally. The main route for extrarenal excretion of LCAR is the hepatobiliary system. Additionally, LCAR was shown to be exposed to recirculation in the biliary system (30) . NAC, on the other hand, passes heavily into the liver tissue after being absorbed. Glutathion, the production of which was induced by NAC, was shown to be deposited substantially in the portal vein in some studies (31, 32) . It has been demonstrated in many recent studies that free oxygen metabolites play a basic role in the mechanism of hepatotoxicity of various substances and medical agents (33) (34) (35) . Oxidative stress also takes part in the hepatotoxic effect of CCl 4 and its negative effect has been shown through some experimental studies to be alleviated by various antioxidant agents (36) (37) (38) (39) .
In addition, lipid peroxidation is known to play a basic role in the injury to the cell membrane through free oxygen radicals. MDA is frequently used in the measurement of lipid peroxide levels and is well correlated with the degree of lipid peroxidation (40) . The levels of MDA increased due to the hepatotoxic effects of CCl 4 and this increase was demonstrated to slow down with the addition of antioxidant agents such as LCAR and NAC used in our study (15, 16, 41) . In addition to the direct damaging effect on the tissues, free radicals are supposed to induce the accumulation of leukocytes in the tissue and hence trigger the tissue injury indirectly through activated neutrophils. It was demonstrated that activated neutrophils accumulated in the infl ammation site and secreted MPO to the extracellular spaces and converted hydroperoxides to free radicals and hence initiated lipid peroxidation (42) . MPO, which exists in high levels in neutrophils, is used as an effi cient digital indicator of infl ammation. The level of MDA and activity of MPO were observed to increase signifi cantly in the CCl 4 group compared to the control and to decrease signifi cantly in the treatment groups compared to the control. These results may show that either NAC or LCAR alone, or combined treatment impede the progress of lipid peroxidation injury and degree of infl ammation caused by CCl 4 .
On the other hand, as the result of evaluation of liver enzymes, the levels of ALT and AST were shown to increase signifi cantly in CCl 4 group and decrease markedly following the administration of LCAR and NAC. However, the decrease in liver enzymes was statistically signifi cant only in NAC + LCAR group. This result demonstrates that combined therapeutic use of NAC and LCAR is more effective in decreasing the liver enzymes.
GSH is a thiol compound in tripeptide structure, which exists in all mammalian cells and protects the cells against free radicals and toxic metabolites. GSH and other thiol containing compounds provide the cell viability and membrane stability against cellular and tissue injury induced by chemical substances. GSH plays an important role in the toxifi cation of various drugs and chemical substances. Liver protecting role of thiol compounds such as GSH primarily, was shown in many studies (43) (44) (45) . The levels of GSH were demonstrated to decrease signifi cantly due to hepatotoxic effects of CCl 4 and this effect was also shown to be lessened by various antioxidant substances (46) (47) (48) .
GSH and CoA were found to be closely associated with each other (49) . Carnitine has an essential role in the release of acyl groups from CoA. The release of acyl groups is important in the oxidation of alpha ketoglutarate from the metabolization of pyruvate and fatty acids. NAC was shown in various studies to increase the levels of glutathion since it is a sulfhydryl source. In addition, decreased levels of GSH in the liver tissue due to CCl 4 exposure were demonstrated to increase with the treatment of LCAR and NAC in many experimental studies (15) . In the current study, it was observed that GSH levels decreased signifi cantly only in CCl 4 group compared to the control and approximated to the control levels again by increasing following the administration of LCAR and NAC.
SOD bears an essential role for the protection against oxidative stress (50) . It is a metalloprotein inducing the conversion of superoxide to hydrogen peroxide and hence prevents the formation of free radicals. On the other hand, CAT is an enzyme responsible for the detoxifi cation of hydrogen peroxide under the catalyzing effect of SOD. In our study, SOD activity was demonstrated not to show any change in both CCl 4 and treatment groups, however, the levels of CAT were found to decrease markedly due to administration of CCl 4 and increase again signifi cantly following the treatment with NAC and LCAR. In the previous experimental liver injury studies conducted by CCl 4 , the levels of SOD and CAT were detected to decrease and later increase after the treatment with antioxidant agents. However, in some other studies, SOD levels were determined not to change signifi cantly parallel to the results obtained in our study (51, 52) .
In the histopathological results of our study, only diffuse hepatosteatosis was determined as one of the acute effects of CCl 4 . Moreover, no signifi cant difference was detected between the CCl 4 and treatment groups from the aspect of hepatosteatosis. Furthermore, other fi ndings such as necrosis, infl ammation or fi brosis detected in some other studies were not observed in our study. Since the histopathological response was inconclusive even though the biochemical results obtained were remarkable, it was thought that the toxicity period was insuffi cient and long-term toxicity studies with different doses of antioxidant treatment would be benefi cial in further research.
In conclusion, antioxidant LCAR and NAC have liver protecting features against acute liver damage formed by CCl 4 according to the results obtained in this study. On the other hand, it was demonstrated that transaminase levels (ALT, AST) which are markers of liver damage increased signifi cantly by CCl 4 and decreased effectively especially in NAC and LCAR combination group. Furthermore, no additional pathology was found except diffuse steatosis in histopathologic examination in both injury model and treatment groups. No signifi cant difference was observed among the groups in the histopathologic examination. Therefore, studies investigating more prolonged toxicity models and treatment options with different doses were thought to be benefi cial. This study was concluded to lead the usage of novel medications as a supplementary therapy in the treatment of acute liver failure.
